Attached files

file filename
EX-31.4 - EX-31.4 - MERRIMACK PHARMACEUTICALS INCd377068dex314.htm
10-K/A - 10-K/A - MERRIMACK PHARMACEUTICALS INCd377068d10ka.htm

Exhibit 31.3

CERTIFICATIONS

I, Richard Peters, M.D., Ph.D., certify that:

1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Merrimack Pharmaceuticals, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: May 1, 2017   

/s/ Richard Peters, M.D., Ph.D.

   Richard Peters, M.D., Ph.D.
   President and Chief Executive Officer
   (Principal Executive Officer)